22 febrero 2013

Yondelis /// Janssen Research & Development, LLC Completa la Fase I : A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies .

Updated :2013_02_19
This study has been completed.

Descriptive Information :
Official title : An Open-Label, Multicenter Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Subjects With Advanced Malignancies . Brief summary :

The purpose of this study is too evaluate the potential effects of ketoconazole on blood levels of tradbectedin after administration to patients with advanced malignancies.
...

  Recruitment Information :

Status : Completed

Start date : 2011-02

Last follow-up date : 2013-02 (Actual)

Primary completion date  : 2012-11 (Actual)

******************************************  

Administrative Data : 

Organization name : Janssen Research & Development, LLC

Organization  ID :  ET7430VC1003 (Janssen Research & Development, LLC)

Sponsor : Janssen Research & Development, LLC

Collaborator : Pharma Mar, S. A. (Pharma Mar)

Health Authority : United States: Food and Drug Administration

...